| Lauren May, MS CCC-SLP | |
|
1620 Tiffany Way, San Jose, CA 95125-5051 | |
| (408) 250-2047 | |
| Not Available |
| Full Name | Lauren May |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1620 Tiffany Way, San Jose, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043072663 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP18664 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lauren May, MS CCC-SLP 1620 Tiffany Way, San Jose, CA 95125-5051 Ph: (408) 250-2047 | Lauren May, MS CCC-SLP 1620 Tiffany Way, San Jose, CA 95125-5051 Ph: (408) 250-2047 |
News Archive
Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.
EndoGastric Solutions (EGS) today announced the closing of a $21.5 Million Series E financing. The funding will be used to support an expanding commercial presence for the company's market-leading Natural Orifice Surgery (NOS) platform, which includes the EsophyX and StomaphyX surgical devices.
N-acetylcysteine, when combined with group cognitive behavioral therapy, reduced symptoms of posttraumatic stress disorder (PTSD), cravings, and depression significantly more than CBT alone in veterans with co-occurring PTSD and substance use disorder, a particularly difficult-to-treat population, according to the findings of a randomized controlled pilot trial conducted by researchers at the Medical University of South Carolina and the Ralph H. Johnson VA Medical Center.
Through a randomized, double-blind, placebo-controlled phase II clinical trial, researchers at University of California San Diego School of Medicine report that small doses of NGM282, a non-tumorigenic variant of an endocrine gastrointestinal hormone, can significantly and rapidly decrease liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
› Verified 6 days ago
Mrs. Noreen Yokoyama-chan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1101 S Winchester Blvd, San Jose, CA 95128 Phone: 408-425-0012 | |
Liana Mehawej, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4010 Moorpark Ave, Suite 117, San Jose, CA 95117 Phone: 408-249-0770 | |
Amy Kilby, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Charcot Ave, Suite 110, San Jose, CA 95131 Phone: 650-336-3383 | |
Ms. Amy C Haught, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 911 Bern Ct Ste 130, San Jose, CA 95112 Phone: 408-666-0355 | |
Jessica Roberson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 330 Crescent Village Circle, San Jose, CA 95134 Phone: 858-883-5400 | |
Christy Picetti, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1485 Saratoga Ave, Suite 200, San Jose, CA 95129 Phone: 877-991-0009 | |
Cecilia Deng, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1101 S Winchester Blvd Ste B110, San Jose, CA 95128 Phone: 408-484-1028 |